Renal function and safety in stable kidney transplant recipients converted from immediate-release to prolonged-release tacrolimus
Author:
Publisher
Frontiers Media SA
Subject
Transplantation
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1432-2277.2011.01366.x/fullpdf
Reference20 articles.
1. Medication noncompliance and its implications in transplant recipients;Morrissey;Drugs,2007
2. Race and electronically measured adherence to immunosuppressive medications after deceased donor renal transplantation;Weng;J Am Soc Nephrol,2005
3. Treatment adherence in renal transplant recipients: a questionnaire survey on immunosuppressants;Ichimaru;Transplant Proc,2008
4. Tacrolimus once daily (ADVAGRAF) versus twice daily (PROGRAF) in de novo renal transplantation: a randomized phase III study;Kramer;Am J Transplant,2010
5. One-year results with extended-release tacrolimus/MMF, tacrolimus/MMF and cyclosporine/MMF in de novo kidney transplant recipients;Silva;Am J Transplant,2007
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Renal Function and Patient-Reported Outcomes in Stable Kidney Transplant Patients Following Conversion From Twice-Daily Immediate-Release Tacrolimus to Once-Daily Prolonged-Release Tacrolimus: A 12-Month Observational Study in Routine Clinical Practice in Germany (ADAGIO);Transplantation Proceedings;2021-06
2. Ten-Year Efficacy and Safety of Once-Daily Tacrolimus in Kidney Transplant: A Prospective Cohort Study;Transplantation Proceedings;2020-12
3. A Prospective, Observational Study of Conversion From Immediate- to Prolonged-Release Tacrolimus in Renal Transplant Recipients in France: The OPALE Study;Annals of Transplantation;2019-09-03
4. A non-randomized trial of conversion from ciclosporin and tacrolimus to tacrolimus MR4 in stable long-term kidney transplant recipients: Graft function and influences of ABCB1 genotypes;PLOS ONE;2019-07-02
5. Children deserve the same level of post-transplant care as adults: Role of extemporaneous formulations and conversion to licensed formulations;Pediatric Transplantation;2018-04-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3